Results of GM and Scheme calculations (5263Z)
2012年3月16日 - 9:58PM
RNSを含む英国規制内ニュース (英語)
TIDMLGIV
RNS Number : 5263Z
Longbow Growth and Income VCT
16 March 2012
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART
IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR south
africa OR any jurisdiction in which the same could be unlawful. the
information contained herein does not constitute an offer of
securities for sale in any jurisdiction, including in the united
states, CANADA, australia, japan OR south africa.
16 March 2012
LONGBOW GROWTH AND INCOME VCT PLC
RESULTS OF GENERAL MEETING HELD ON 16 MARCH 2012 AND SCHEME
CALCULATIONS
Longbow Growth and Income VCT plc (the "Company") refers to the
circular published by the Company on 10 February 2012 and announces
that at the Second General Meeting, which was held earlier today,
the special resolution to place the Company in members' voluntary
liquidation was passed and the Company is now in liquidation. A
copy of this resolution has been submitted to the National Storage
Mechanism and will shortly be available for inspection at
http://www.hemscott.com/nsm.do. Details of the number of proxy
votes cast for, against and withheld on the resolution will be
published on the Company's website, www.longbow.co.uk.
The Company also announces that it has forfeited and cancelled a
further 10,200 Ordinary Shares allocated pursuant to its offer for
subscription in July 2011 in respect of which the issue price
remains unpaid. The Company now has 1,047,392 Ordinary Shares in
issue, each with voting rights. Under the terms of the Scheme,
details of which were set out in the Circular, the FAV per LGIV
Share, calculated on the basis of the net asset value of the
Company as at close of business on 13 March 2012 (the "Calculation
Date") was 88.92 pence and the FAV per ProVen Health VCT Share was
43.30 pence. Based on the FAV per LGIV Share and the FAV per ProVen
Health VCT Share set out above, an LGIV Shareholder will receive
approximately 2.05 New ProVen Health VCT Shares under the Scheme in
respect of each such Ordinary Share held. The New ProVen Health VCT
Shares to be issued pursuant to the Scheme will be admitted to the
premium segment of the Official List and to trading on the London
Stock Exchange's main market for listed securities on 19 March 2012
and the first day of dealings in such securities will be 19 March
2012.
Capitalised terms shall bear the meanings given to them in the
Circular published by the Company on 10 February 2012 unless the
context otherwise requires.
Enquiries:
Edward Beckett
Longbow Capital LLP 020 7332 0320
Robin Smeaton 0131 243 7210
The City Partnership (UK)
Limited, Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMLLFEFVRIRLIF
Longbow (LSE:LGIV)
過去 株価チャート
から 4 2024 まで 5 2024
Longbow (LSE:LGIV)
過去 株価チャート
から 5 2023 まで 5 2024